_what-is-folfiri-chemotherapy-preview-1.jpg "What is FOLFIRI Chemotherapy? from folfiri Video Screenshot Preview 1")
Gallery_what-is-folfiri-chemotherapy-preview-3.jpg "What is FOLFIRI Chemotherapy? from folfiri Video Screenshot Preview 3")
Gallery_what-is-folfiri-chemotherapy-preview-hqdefault.jpg "What is FOLFIRI Chemotherapy? from folfiri Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 3 minutes 2 seconds
👁 View: 89 times
Play Audio:👁 View: 89 times
Description:
Thriving Strong
Thriving Strong
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_heinz-josef-lenz-md-and-marc-ychou-md-on-treating-mcrc-with-initially-non-resectable-liver-metastases.webp "Heinz-Josef Lenz, MD, of the University of Southern California, and Marc Ychou, MD, of the Centre Régional de Lutte Contre Le Cancer, discuss study findings on FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with initially non-resectable liver metastases (Abstract 3512).")
⏲ 3 min 5 sec ✓ 08-Jun-2016
_tribe-2-folfox-or-folfiri-with-bevacizumab-in-mcrc.webp "OncLiveTV")
_aflibercept-plus-folfiri-in-polish-patients-with-metastatic-colorectal-cancer.webp "VJOncology")
⏲ 2 minutes 29 seconds 👁 72
_colorectal-cancer-understanding-the-impact-of-results-from-calgb-swog-80405-plenary-folfiri-or-mfolfox6-with-beva.webp "The ASCO Post is pleased to present this special video series of interviews by and with leaders in oncology as recorded live at ASCO's 50th Annual Meeting in Chicago. Click on the thumbnail to view the entire interview.nnAlok A. Khorana, MD, Director, GI Malignancies Program, Vice Chair for Clinical Sciences, Taussig Cancer Center, Cleveland Clinic, discusses the CALGB/SWOG 80405 study presented during the plenary session at this year's ASCO Annual Meeting.")
⏲ 3 min 89 sec ✓ 20-Jun-2014
_what-is-folfiri-chemotherapy.webp "Thriving Strong")
_esmo-2022-highlights-commentary-and-analysis.webp "Dr Bishal casts his ascerbic eye over the key studies from ESMO 2022.nnStarting with a commentary on the difficulties of oncologists from LMICs attending such meetings, he goes on to cover both the early cancer setting and de-escalation of treatmentnnHe covers the following studies:nn- CANOPY-A: Phase III study of canakinumab as adjuvant therapy in patients with completely resected non-small cell lung cancernn- Charles Swanton / air pollutionnn- IMmotion010: Efficacy and safety from the phase II")
_understanding-your-treatment-folfiri-avastin-therapy.webp "charlottecancer")
_folfiri-side-effects.webp "Shannon Warr")
_heinz-josef-lenz-md-and-marc-ychou-md-on-treating-mcrc-with-initially-non-resectable-liver-metastases.jpg)
_tribe-2-folfox-or-folfiri-with-bevacizumab-in-mcrc.jpg)
_aflibercept-plus-folfiri-in-polish-patients-with-metastatic-colorectal-cancer.jpg)
_colorectal-cancer-understanding-the-impact-of-results-from-calgb-swog-80405-plenary-folfiri-or-mfolfox6-with-beva.jpg)
_what-is-folfiri-chemotherapy.jpg)
_esmo-2022-highlights-commentary-and-analysis.jpg)
_understanding-your-treatment-folfiri-avastin-therapy.jpg)
_folfiri-side-effects.jpg)
![[+]](/images/menu.gif){kind=small}